A patient is diagnosed with a rare disease that affects the dynamics of the actin cytoskeleton, specifically interfering with the polymerization of actin filaments at the cell membrane. The disease causes difficulties in wound healing, immune response, and cell movement. If researchers develop a therapeutic approach to enhance the nucleation of actin filaments, what would be the most likely outcome at the cellular level, and how could this intervention impact the patient’s condition?

A. The enhancement of actin polymerization at the cell membrane would likely improve cellular protrusions, leading to faster migration and healing

B. Enhancing actin polymerisation would cause excessive cell movement, leading to uncontrolled cell proliferation and potentially worsening the patient’s condition

C. Intervention would have no effect on the patient’s condition, as actin polymerization is not involved in wound healing or immune responses

D. Enhancing actin polymerisation would only impact muscle cells, making it irrelevant for treating the disease in other cell types